{"id":7357,"date":"2026-04-05T07:23:45","date_gmt":"2026-04-05T10:23:45","guid":{"rendered":"https:\/\/oexpressobr.com.br\/?p=7357"},"modified":"2026-04-05T07:23:47","modified_gmt":"2026-04-05T10:23:47","slug":"anvisa-e-farmaceuticas-travam-queda-de-braco-apos-fim-da-patente-da-semaglutida-no-brasil","status":"publish","type":"post","link":"https:\/\/oexpressobr.com.br\/?p=7357","title":{"rendered":"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil"},"content":{"rendered":"\n

\u200bA exclusividade da Novo Nordisk<\/strong> sobre a semaglutida<\/strong> \u2014 o princ\u00edpio ativo dos cobi\u00e7ados Ozempic<\/strong> e Wegovy<\/strong> \u2014 chegou oficialmente ao fim no Brasil em 20 de mar\u00e7o de 2026<\/strong>. Ap\u00f3s anos de dom\u00ednio absoluto e uma tentativa judicial frustrada da fabricante dinamarquesa para estender o prazo at\u00e9 2038, o mercado brasileiro tornou-se, tecnicamente, um campo aberto. No entanto, o consumidor que correu \u00e0s farm\u00e1cias em busca de um gen\u00e9rico barato encontrou as mesmas prateleiras de sempre.<\/p>\n\n\n\n

\u200bA transi\u00e7\u00e3o entre o “fim do monop\u00f3lio” e a “chegada do gen\u00e9rico” enfrenta um gargalo que mistura rigor sanit\u00e1rio e complexidade industrial.<\/p>\n\n\n\n

\u200bPor que o pre\u00e7o ainda n\u00e3o caiu?<\/h3>\n\n\n\n

\u200bEmbora a patente tenha expirado, a produ\u00e7\u00e3o de um medicamento gen\u00e9rico n\u00e3o \u00e9 autom\u00e1tica. Existem tr\u00eas barreiras principais que mant\u00eam os pre\u00e7os elevados no curto prazo:<\/p>\n\n\n\n

    \n
  1. \u200bFila de aprova\u00e7\u00e3o na Anvisa:<\/strong> Atualmente, a ag\u00eancia reguladora analisa cerca de 17 pedidos de registro<\/strong> para medicamentos \u00e0 base de semaglutida. Gigantes nacionais como EMS<\/strong>, Crist\u00e1lia<\/strong> e \u00c1vita Care<\/strong> lideram essa corrida, mas o processo de an\u00e1lise de bioequival\u00eancia e seguran\u00e7a \u00e9 rigoroso e pode levar meses.<\/li>\n\n\n\n
  2. \u200bComplexidade da caneta aplicadora:<\/strong> Diferente de um comprimido comum, o Ozempic utiliza uma tecnologia de injetores de precis\u00e3o. Produzir a semaglutida sint\u00e9tica \u00e9 um desafio, mas fabricar o dispositivo de aplica\u00e7\u00e3o em escala industrial exige investimentos que poucas farmac\u00eauticas brasileiras dominam plenamente.<\/li>\n\n\n\n
  3. \u200bLog\u00edstica de insumos:<\/strong> A alta demanda global pela mat\u00e9ria-prima da semaglutida gera uma competi\u00e7\u00e3o internacional por fornecedores, o que impede uma redu\u00e7\u00e3o dr\u00e1stica de custos de produ\u00e7\u00e3o neste primeiro momento.<\/li>\n<\/ol>\n\n\n\n

    \u200bQuando as vers\u00f5es mais baratas chegam?<\/h3>\n\n\n\n

    \u200bA expectativa do setor farmac\u00eautico \u00e9 otimista para o segundo semestre de 2026<\/strong>.<\/p>\n\n\n\n

      \n
    • \u200bEMS:<\/strong> A farmac\u00eautica brasileira planeja colocar suas primeiras unidades no mercado at\u00e9 setembro de 2026<\/strong>, com a meta audaciosa de produzir 1 milh\u00e3o de canetas ainda este ano.<\/li>\n\n\n\n
    • \u200bRedu\u00e7\u00e3o de pre\u00e7os:<\/strong> Analistas de mercado estimam que os primeiros gen\u00e9ricos cheguem com um valor entre 20% e 30% menor<\/strong> que o produto original. No longo prazo, com o aumento da concorr\u00eancia, essa queda pode atingir 40%<\/strong>.<\/li>\n\n\n\n
    • \u200bParcerias estrat\u00e9gicas:<\/strong> A Eurofarma<\/strong> optou por um caminho diferente, lan\u00e7ando vers\u00f5es (como o Poviztra<\/em>) em parceria direta com a pr\u00f3pria Novo Nordisk, o que garante a tecnologia original, mas mant\u00e9m o pre\u00e7o em patamares ainda elevados.<\/li>\n<\/ul>\n\n\n\n

      \u200bO impacto no SUS<\/h3>\n\n\n\n

      \u200bO fim da patente reacendeu o debate em Bras\u00edlia sobre a incorpora\u00e7\u00e3o do medicamento no Sistema \u00danico de Sa\u00fade (SUS)<\/strong>. O Minist\u00e9rio da Sa\u00fade sinalizou que a queda de pre\u00e7os decorrente da concorr\u00eancia \u00e9 o fator determinante para viabilizar a oferta gratuita do tratamento para obesidade e diabetes tipo 2, algo que antes era considerado financeiramente insustent\u00e1vel (estimado em R$ 8 bilh\u00f5es anuais).<\/p>\n\n\n\n

      \n

      \u200bAten\u00e7\u00e3o:<\/strong> Medicamentos \u00e0 base de semaglutida devem ser utilizados apenas sob prescri\u00e7\u00e3o e acompanhamento m\u00e9dico, devido aos riscos de efeitos colaterais graves e contraindica\u00e7\u00f5es espec\u00edficas.<\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"

      \u200bA exclusividade da Novo Nordisk sobre a semaglutida \u2014 o princ\u00edpio ativo dos cobi\u00e7ados Ozempic e Wegovy \u2014 chegou oficialmente ao fim no Brasil em […]<\/p>\n","protected":false},"author":1,"featured_media":7358,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAowsargCw:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[18],"tags":[],"class_list":["post-7357","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saude"],"desktop_mode_lock":null,"desktop_mode_contributors":[],"desktop_mode_attached_media":[7358],"yoast_head":"\nAnvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil - O Expresso BR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/oexpressobr.com.br\/?p=7357\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil - O Expresso BR\" \/>\n<meta property=\"og:description\" content=\"\u200bA exclusividade da Novo Nordisk sobre a semaglutida \u2014 o princ\u00edpio ativo dos cobi\u00e7ados Ozempic e Wegovy \u2014 chegou oficialmente ao fim no Brasil em [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oexpressobr.com.br\/?p=7357\" \/>\n<meta property=\"og:site_name\" content=\"O Expresso BR\" \/>\n<meta property=\"article:author\" content=\"https:\/\/www.facebook.com\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-05T10:23:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-05T10:23:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/oexpressobr.com.br\/wp-content\/uploads\/2026\/04\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Julio Take\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Julio Take\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357\"},\"author\":{\"name\":\"Julio Take\",\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/#\\\/schema\\\/person\\\/56e062614cf5b5bd8d8a675f03762735\"},\"headline\":\"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil\",\"datePublished\":\"2026-04-05T10:23:45+00:00\",\"dateModified\":\"2026-04-05T10:23:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357\"},\"wordCount\":525,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/oexpressobr.com.br\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1\",\"articleSection\":[\"Sa\u00fade\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357\",\"url\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357\",\"name\":\"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil - O Expresso BR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/oexpressobr.com.br\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1\",\"datePublished\":\"2026-04-05T10:23:45+00:00\",\"dateModified\":\"2026-04-05T10:23:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/oexpressobr.com.br\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/oexpressobr.com.br\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/?p=7357#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/oexpressobr.com.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/#website\",\"url\":\"https:\\\/\\\/oexpressobr.com.br\\\/\",\"name\":\"O Expresso BR\",\"description\":\"\u00c9 um site de not\u00edcias com sede em Maring\u00e1-PR\",\"publisher\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/oexpressobr.com.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/#organization\",\"name\":\"Jornal online\",\"url\":\"https:\\\/\\\/oexpressobr.com.br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/oexpressobr.com.br\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cropped-cropped-cropped-cropped-cropped-Oexpressobr-1536x281-1-1.jpg?fit=1373%2C279&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/oexpressobr.com.br\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cropped-cropped-cropped-cropped-cropped-Oexpressobr-1536x281-1-1.jpg?fit=1373%2C279&ssl=1\",\"width\":1373,\"height\":279,\"caption\":\"Jornal online\"},\"image\":{\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/oexpressobr.com.br\\\/#\\\/schema\\\/person\\\/56e062614cf5b5bd8d8a675f03762735\",\"name\":\"Julio Take\",\"pronouns\":\"I Expresso BR\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/db07b4d4a38728c122c1336a3af60b3267f49fc8004b22b5bd1b602ecd2517c3?s=96&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/db07b4d4a38728c122c1336a3af60b3267f49fc8004b22b5bd1b602ecd2517c3?s=96&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/db07b4d4a38728c122c1336a3af60b3267f49fc8004b22b5bd1b602ecd2517c3?s=96&r=g\",\"caption\":\"Julio Take\"},\"description\":\"Julio Take, jornalista e fot\u00f3grafo. Editor do O Expresso BR.\",\"sameAs\":[\"http:\\\/\\\/oexpressobr.com.br\",\"https:\\\/\\\/www.facebook.com\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@juliotake783\"],\"url\":\"https:\\\/\\\/oexpressobr.com.br\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil - O Expresso BR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/oexpressobr.com.br\/?p=7357","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil - O Expresso BR","og_description":"\u200bA exclusividade da Novo Nordisk sobre a semaglutida \u2014 o princ\u00edpio ativo dos cobi\u00e7ados Ozempic e Wegovy \u2014 chegou oficialmente ao fim no Brasil em [...]","og_url":"https:\/\/oexpressobr.com.br\/?p=7357","og_site_name":"O Expresso BR","article_author":"https:\/\/www.facebook.com\/","article_published_time":"2026-04-05T10:23:45+00:00","article_modified_time":"2026-04-05T10:23:47+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/i0.wp.com\/oexpressobr.com.br\/wp-content\/uploads\/2026\/04\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1","type":"image\/jpeg"}],"author":"Julio Take","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Julio Take","Est. tempo de leitura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oexpressobr.com.br\/?p=7357#article","isPartOf":{"@id":"https:\/\/oexpressobr.com.br\/?p=7357"},"author":{"name":"Julio Take","@id":"https:\/\/oexpressobr.com.br\/#\/schema\/person\/56e062614cf5b5bd8d8a675f03762735"},"headline":"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil","datePublished":"2026-04-05T10:23:45+00:00","dateModified":"2026-04-05T10:23:47+00:00","mainEntityOfPage":{"@id":"https:\/\/oexpressobr.com.br\/?p=7357"},"wordCount":525,"commentCount":0,"publisher":{"@id":"https:\/\/oexpressobr.com.br\/#organization"},"image":{"@id":"https:\/\/oexpressobr.com.br\/?p=7357#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/oexpressobr.com.br\/wp-content\/uploads\/2026\/04\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1","articleSection":["Sa\u00fade"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/oexpressobr.com.br\/?p=7357#respond"]}]},{"@type":"WebPage","@id":"https:\/\/oexpressobr.com.br\/?p=7357","url":"https:\/\/oexpressobr.com.br\/?p=7357","name":"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil - O Expresso BR","isPartOf":{"@id":"https:\/\/oexpressobr.com.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oexpressobr.com.br\/?p=7357#primaryimage"},"image":{"@id":"https:\/\/oexpressobr.com.br\/?p=7357#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/oexpressobr.com.br\/wp-content\/uploads\/2026\/04\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1","datePublished":"2026-04-05T10:23:45+00:00","dateModified":"2026-04-05T10:23:47+00:00","breadcrumb":{"@id":"https:\/\/oexpressobr.com.br\/?p=7357#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oexpressobr.com.br\/?p=7357"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/oexpressobr.com.br\/?p=7357#primaryimage","url":"https:\/\/i0.wp.com\/oexpressobr.com.br\/wp-content\/uploads\/2026\/04\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1","contentUrl":"https:\/\/i0.wp.com\/oexpressobr.com.br\/wp-content\/uploads\/2026\/04\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/oexpressobr.com.br\/?p=7357#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/oexpressobr.com.br\/"},{"@type":"ListItem","position":2,"name":"Anvisa e farmac\u00eauticas travam queda de bra\u00e7o ap\u00f3s fim da patente da semaglutida no Brasil"}]},{"@type":"WebSite","@id":"https:\/\/oexpressobr.com.br\/#website","url":"https:\/\/oexpressobr.com.br\/","name":"O Expresso BR","description":"\u00c9 um site de not\u00edcias com sede em Maring\u00e1-PR","publisher":{"@id":"https:\/\/oexpressobr.com.br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oexpressobr.com.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/oexpressobr.com.br\/#organization","name":"Jornal online","url":"https:\/\/oexpressobr.com.br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/oexpressobr.com.br\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/oexpressobr.com.br\/wp-content\/uploads\/2026\/01\/cropped-cropped-cropped-cropped-cropped-Oexpressobr-1536x281-1-1.jpg?fit=1373%2C279&ssl=1","contentUrl":"https:\/\/i0.wp.com\/oexpressobr.com.br\/wp-content\/uploads\/2026\/01\/cropped-cropped-cropped-cropped-cropped-Oexpressobr-1536x281-1-1.jpg?fit=1373%2C279&ssl=1","width":1373,"height":279,"caption":"Jornal online"},"image":{"@id":"https:\/\/oexpressobr.com.br\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/oexpressobr.com.br\/#\/schema\/person\/56e062614cf5b5bd8d8a675f03762735","name":"Julio Take","pronouns":"I Expresso BR","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/db07b4d4a38728c122c1336a3af60b3267f49fc8004b22b5bd1b602ecd2517c3?s=96&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/db07b4d4a38728c122c1336a3af60b3267f49fc8004b22b5bd1b602ecd2517c3?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/db07b4d4a38728c122c1336a3af60b3267f49fc8004b22b5bd1b602ecd2517c3?s=96&r=g","caption":"Julio Take"},"description":"Julio Take, jornalista e fot\u00f3grafo. Editor do O Expresso BR.","sameAs":["http:\/\/oexpressobr.com.br","https:\/\/www.facebook.com\/","https:\/\/www.youtube.com\/@juliotake783"],"url":"https:\/\/oexpressobr.com.br\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/oexpressobr.com.br\/wp-content\/uploads\/2026\/04\/IMG-20260405-WA0216.jpg?fit=1080%2C1080&ssl=1","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=\/wp\/v2\/posts\/7357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7357"}],"version-history":[{"count":1,"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=\/wp\/v2\/posts\/7357\/revisions"}],"predecessor-version":[{"id":7359,"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=\/wp\/v2\/posts\/7357\/revisions\/7359"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=\/wp\/v2\/media\/7358"}],"wp:attachment":[{"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oexpressobr.com.br\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}